Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 11/20 | 0.47 |
| ▸ | LNPEP | Q9UIQ6 | 10/20 | 0.47 |
| ▸ | ERAP1 | Q9NZ08 | 5/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.43 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.43 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.43 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.43 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.43 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.43 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.43 |
| ▸ | SUV39H2 | Q9H5I1 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21371991 | 1.00 | ERAP2 (0.47) | ERAP2LNPEPERAP1HDAC1HDAC3 | |
| SCHEMBL21371923 | 1.00 | ERAP2 (0.47) | ERAP2LNPEPERAP1HDAC1HDAC3 | |
| SCHEMBL21371992 | 1.00 | ERAP2 (0.47) | ERAP2LNPEPERAP1HDAC1HDAC3 | |
| SCHEMBL19445724 | 0.99 | ERAP2 (0.47) | ERAP2LNPEPERAP1HDAC1HDAC3 | |
| SCHEMBL12515364 | 0.99 | ERAP2 (0.47) | ERAP2LNPEPERAP1HDAC1HDAC3 | |
| SCHEMBL19445798 | 0.99 | ERAP2 (0.47) | ERAP2LNPEPERAP1HDAC1HDAC3 | |
| SCHEMBL10260969 | 0.99 | ERAP2 (0.47) | ERAP2LNPEPERAP1HDAC1HDAC3 | |
| SCHEMBL12515355 | 0.99 | ERAP2 (0.47) | ERAP2LNPEPERAP1HDAC1HDAC3 | |
| SCHEMBL21371933 | 0.95 | ERAP2 (0.44) | ERAP2LNPEPERAP1HDAC1HDAC3 | |
| SCHEMBL19445847 | 0.94 | ERAP2 (0.45) | ERAP2LNPEPERAP1HDAC1HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10206894-B2 | Compounds for use in treatment of mucositis | INNOVATION PHARMACEUTICALS INC. (US) | 2019-02-19 | — | — | US | disclosed |
| US-20180064664-A1 | Compounds For Use In Treatment of Mucositis | POLYMEDIX, INC. | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10206894-B2 | Compounds for use in treatment of mucositis | MUC1, FUT6, SI | ERAP2 692/4885LNPEP 802/4885ERAP1 1246/4885 |
| US-20180064664-A1 | Compounds For Use In Treatment of Mucositis | MUC1, FUT6, SI | ERAP2 692/4885LNPEP 802/4885ERAP1 1246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.